Rosacea News and Research

RSS
Rosacea is a common and chronic skin condition characterized by flushing, burning and stinging of the skin. The symptoms mainly appear on the face, often affecting the nose, cheeks and chin. Whilst it is not known exactly what causes rosacea, certain triggers have been identified. Common risk factors include sunlight exposure and hot weather, stress, certain foods and drinks, strenuous exercise and some medications.

Rosacea is estimated to affect up to 10% of people, with those aged between 30 and 50 being the most commonly affected. Whilst women tend to develop the condition more frequently than men, the symptoms of rosacea often present more severely in men.

Treatments for rosacea focus on managing the symptoms, as there is currently no cure for the condition. Identifying triggers and learning to avoid them play a large role in easing symptoms. Certain medicines, both topical and oral, may also be used to help control flare ups.
Proper skin care, cosmetics can improve skin of acne and rosacea patients

Proper skin care, cosmetics can improve skin of acne and rosacea patients

Vicept reports positive data from V-101 Phase II clinical trial for Type I Rosacea

Vicept reports positive data from V-101 Phase II clinical trial for Type I Rosacea

KYTHERA and Intendis initiate ATX-101 European Phase III studies for reduction of submental fat

KYTHERA and Intendis initiate ATX-101 European Phase III studies for reduction of submental fat

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

Obagi Medical Products prices secondary offering

Obagi Medical Products prices secondary offering

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

NIAMS awards $684,000 SBIR grant to Signum Biosciences to develop GPCR modulating therapeutics

NIAMS awards $684,000 SBIR grant to Signum Biosciences to develop GPCR modulating therapeutics

Quick-Med receives patent for MultiStat technology to treat Rosacea

Quick-Med receives patent for MultiStat technology to treat Rosacea

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

V-101 shows safety profile in treating erythema of rosacea: Clinical study

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Price of sun overindulgence and tanning misuse is not just skin deep

Price of sun overindulgence and tanning misuse is not just skin deep

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

Rohto launches AFC Medirepair with Signum's compound Arazine in Japan

Rohto launches AFC Medirepair with Signum's compound Arazine in Japan

Vicept completes $16 million Series A financing

Vicept completes $16 million Series A financing

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

Helix BioMedix reports revenue of approximately $391,000 in 2009

Helix BioMedix reports revenue of approximately $391,000 in 2009

Galderma Laboratories' Differin Lotion receives FDA approval

Galderma Laboratories' Differin Lotion receives FDA approval

Proper diagnosis, treatment and good skin care help control acne and rosacea

Proper diagnosis, treatment and good skin care help control acne and rosacea

freshHAIR: A new hair care line to prevent acne

freshHAIR: A new hair care line to prevent acne